Atrys Health, S.A. (BME:ATRY)
2.830
-0.040 (-1.39%)
Apr 7, 2026, 5:35 PM CET
Atrys Health Revenue
In the year 2025, Atrys Health had annual revenue of 145.00M EUR, down -33.52%. Atrys Health had revenue of 117.50M in the half year ending June 30, 2025, with 12.60% growth.
Revenue
145.00M
Revenue Growth
-33.52%
P/S Ratio
1.48
Revenue / Employee
71.92K
Employees
2,016
Market Cap
214.72M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 145.00M | -73.10M | -33.52% |
| Dec 31, 2024 | 218.10M | 12.00M | 5.82% |
| Dec 31, 2023 | 206.10M | 42.90M | 26.28% |
| Dec 31, 2022 | 163.20M | 39.35M | 31.77% |
| Dec 31, 2021 | 123.85M | 90.04M | 266.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Grifols | 7.52B |
| Almirall | 1.11B |
| Laboratorios Farmaceuticos Rovi | 743.48M |
| Faes Farma | 626.99M |
| Laboratorio Reig Jofre | 336.68M |
| Clínica Baviera | 304.91M |
| Prim, S.A. | 253.56M |
| Pharma Mar | 221.39M |